Massachusetts Financial Services »

BioCryst Pharmaceuticals shares owned by Massachusetts Financial Services

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Massachusetts Financial Services from 13F filings

Historical chart of Massachusetts Financial Services investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Massachusetts Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Massachusetts Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $1000k 132k 7.59
2025-06-30 $1.1M 123k 8.96

More positions owned by Massachusetts Financial Services

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Mastercard Incorporated Cl A (MA)
Johnson & Johnson (JNJ)
Ubs Group SHS (UBS)
Progressive Corporation (PGR)
Cigna Corp (CI)
Aon Shs Cl A (AON)
McKesson Corporation (MCK)

View all positions for Massachusetts Financial Services

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals